Stock Quote

Moderna to invest $500 million in ‘state-of-the-art’ mRNA vaccine factory in Africa

Moderna, the biotechnology company behind a key COVID-19 vaccine, says it will build a new facility in Africa, aimed at producing up to 500 million doses of vaccines a year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.